GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Issuance of Debt

ImmunoPrecise Antibodies (STU:TQB) Issuance of Debt : €2.72 Mil (TTM As of Oct. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Issuance of Debt?

ImmunoPrecise Antibodies's Issuance of Debt for the three months ended in Oct. 2024 was €0.98 Mil.

ImmunoPrecise Antibodies's Issuance of Debt for the trailing twelve months (TTM) ended in Oct. 2024 was €2.72 Mil.


ImmunoPrecise Antibodies Issuance of Debt Historical Data

The historical data trend for ImmunoPrecise Antibodies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Issuance of Debt Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 1.47 - - -

ImmunoPrecise Antibodies Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.75 0.98

ImmunoPrecise Antibodies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

ImmunoPrecise Antibodies Headlines

No Headlines